|
Molecular properties generated using the CDK |
Classification ![]() |
|
| Compound class | Synthetic organic |
| Approved drug? | Yes (source: FDA (1993)) |
| Prodrug | gabapentin enacarbil |
IUPAC Name ![]() |
| 2-[1-(aminomethyl)cyclohexyl]acetic acid |
International Nonproprietary Names ![]() |
|
| INN number | INN |
| 5094 | gabapentin |
Synonyms ![]() |
| CI 945 |
| Go 3450 |
| GOE 2450 |
| GOE 3450 |
| Neurontin® |
Database Links ![]() |
|
| CAS Registry No. | 60142-96-3 |
| ChEMBL Ligand | CHEMBL940 |
| DrugBank Ligand | DB00996 |
| Human Metabolome Database | HMDB05015 |
| PubChem CID | 3446 |
| RCSB PDB Ligand | GBN |
| Search Google for chemical match using the InChIKey | UGJMXCAKCUNAIE-UHFFFAOYSA-N |
| Search Google for chemicals with the same backbone | UGJMXCAKCUNAIE |
| Search PubMed clinical trials | gabapentin |
| Search PubMed titles | gabapentin |
| Search PubMed titles/abstracts | gabapentin |
| Wikipedia | Gabapentin |
| Comments |
| Although gabapentin was desigened to mimic gamma-aminobutyric acid (GABA), it is believed that gabapentinoids act on different brain receptors, such as the α2δ subunit of voltage-gated calcium channels. |